Jaguar Health (JAGX) Common Equity (2016 - 2025)
Jaguar Health (JAGX) has disclosed Common Equity for 11 consecutive years, with -$18.7 million as the latest value for Q4 2025.
- Quarterly Common Equity fell 387.77% to -$18.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$18.7 million through Dec 2025, down 387.77% year-over-year, with the annual reading at -$18.7 million for FY2025, 387.77% down from the prior year.
- Common Equity for Q4 2025 was -$18.7 million at Jaguar Health, down from $4.4 million in the prior quarter.
- The five-year high for Common Equity was $31.9 million in Q1 2021, with the low at -$18.7 million in Q4 2025.
- Average Common Equity over 5 years is $8.6 million, with a median of $6.7 million recorded in 2024.
- The sharpest move saw Common Equity skyrocketed 1958.61% in 2021, then plummeted 387.77% in 2025.
- Over 5 years, Common Equity stood at $11.9 million in 2021, then plummeted by 111.47% to -$1.4 million in 2022, then soared by 460.34% to $4.9 million in 2023, then surged by 32.61% to $6.5 million in 2024, then tumbled by 387.77% to -$18.7 million in 2025.
- According to Business Quant data, Common Equity over the past three periods came in at -$18.7 million, $4.4 million, and $6.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.